TickerFacts.

Janux Therapeutics, Inc. (JANX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

61.97M
Year ended 2025-12-31
+14.3%
3-year compound annual growth
2021-12-31: 23.53M2022-12-31: 41.47M2023-12-31: 44.02M2024-12-31: 53.75M2025-12-31: 61.97M61.97M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3161.97M+15.3%2026-02-26, From 2025-01-01
2024-12-3153.75M+22.1%2026-02-26, From 2024-01-01
2023-12-3144.02M+6.1%2026-02-26, From 2023-01-01
2022-12-3141.47M+76.2%2025-02-27, From 2022-01-01
2021-12-3123.53Mn/a2023-03-10, From 2021-01-01